| Humalog pen (insulin lispro) / Eli Lilly |
| Completed | 2b | 157 | US | HDV Insulin Lispro, HDV Humalog, Insulin LISPRO, Humalog | Diasome Pharmaceuticals, Integrium | Type 1 Diabetes Mellitus | 04/18 | 06/18 | | |
NCT00774800: Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus |
|
|
| Completed | 2 | 22 | US | Humalog, Insulin lispro, Humulin-R, Humulin, Recombinant human insulin, Recombinant human hyaluronidase PH20 (rHuPH20), HYLENEX, PH20, Liquid meal, Ensure | Halozyme Therapeutics | Type 1 Diabetes Mellitus | 03/09 | 03/09 | | |
NCT00883558: Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus |
|
|
| Completed | 2 | 48 | US | Insulin Lispro, Humalog, regular human insulin, Humulin R, recombinant human hyaluronidase PH20, Hylenex, rHuPH20, PH20, Insulin glargine, Lantus | Halozyme Therapeutics | Diabetes Mellitus, Type 1 | 02/10 | 04/10 | | |
|
NCT00747006: Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake |
|
|
| Terminated | 2 | 18 | US | TI Inhalation Powder and Humalog (Amendment 1), TI Inhalation Powder (original protocol) | Mannkind Corporation | Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | 02/11 | 05/11 | | |
NCT01194245: Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus |
|
|
| Completed | 2 | 135 | US | Insulin lispro, Humalog, recombinant human hyaluronidase PH20, Hylenex, rHuPH20, PH20, Insulin aspart, Insulin glulisine, Apidra, Insulin glargine, Lantus | Halozyme Therapeutics | Diabetes Mellitus, Type 1 | 08/11 | 08/11 | | |
NCT01686620: A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) |
|
|
| Completed | 2 | 132 | US | BIOD-123, Lispro (Humalog) | Biodel | Type 1 Diabetes Mellitus | 06/13 | 06/13 | | |
|
|
|
NCT02146651 / 2014-000949-77: A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes |
|
|
| Completed | 2 | 38 | Europe | BioChaperone insulin lispro 0.2U/Kg, BioChaperone insulin lispro 0.1U/Kg, BioChaperone insulin lispro 0.4U/Kg, Humalog® | Adocia | Diabetes Mellitus Type 1 | 07/14 | 12/14 | | |
NCT03096392: Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control |
|
|
| Completed | 2 | 46 | US | HDV insulin lispro 100 UNT/ML, Hepatic Directed Vesicle insulin lispro 100 UNT/ML, Insulin Lispro 100 UNT/ML, Humalog | Diasome Pharmaceuticals, Integrium | Diabetes Mellitus, Type 1 | 11/17 | 03/18 | | |
NCT03156361: 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus |
|
|
| Completed | 2 | 24 | US | HDV insulin lispro 100 UNIT/mL, HDV Humalog, Insulin Lispro 100 Units/mL, Humalog | Diasome Pharmaceuticals, Integrium | Type1 Diabetes Mellitus | 01/18 | 03/18 | | |
NCT02213146 / 2014-001432-11: A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes |
|
|
| Completed | 1/2 | 38 | Europe | BioChaperone human insulin, Huminsulin® Normal, Humalog® | Adocia | Diabetes Mellitus Type 1 | 12/14 | 06/15 | | |
NCT02739906: A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM |
|
|
| Completed | 1/2 | 36 | Europe | BioChaperone Human Insulin (HinsBet®), Insulin Lispro (Humalog®), Regular human insulin (Huminsulin® Normal) | Adocia | Type 1 Diabetes Mellitus | 08/16 | 08/16 | | |
